Dr. Paul Charles Guichard, DO

Dr. Guichard practices at Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia.

Dr. Guichard's NPI, 1649269796, was assigned on October 20, 2005. Dr. Guichard graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1996. Dr. Guichard holds Georgia license 54386.

Dr. Guichard's primary practice is Wellstar Pulmonary Medicine - HOPD, at 55 Whitcher Street, Marietta, GA 30060.

Dr. Guichard's primary practice is Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia. Dr. Guichard is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Guichard to 5 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Guichard's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guichard practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Guichard's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Guichard is licensed in Georgia.

CMS data shows 2,092 Medicare services from Dr. Guichard across 22 procedure codes in 2024, for 878 Medicare patients. Medicare paid $139,143 for them.

CMS counts 878 Medicare patients who saw Dr. Guichard in 2024. The largest group is 75 to 84, with 387 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guichard's median patient age at 74, with 50% women.

In 2024, Dr. Guichard wrote 7,652 Medicare Part D claims for 783 patients. 83% of them were for generic drugs. CMS names the drug for 7,412 of them, across 68 drugs with 11 or more claims each, at $5,704,023 in total drug cost. In 2023, CMS named 6,973 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Guichard for performance year 2024, reported through an alternative payment model (APM). Dr. Guichard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Guichard as offering telehealth. CMS counts 61 procedures of coronary angioplasty and stenting by Dr. Guichard, more than 89% of the clinicians it reports for that procedure.

Dmand AI links Dr. Guichard to 1 clinical trial. Conditions studied include Venous Thromboembolism and Pulmonary Embolism.

CMS Open Payments shows 1,059 general payments to Dr. Guichard from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $115,783.

Dr. Guichard graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1996.